1. The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model.
- Author
-
Garcia, Celina, Gustavo Dubois, Luiz, Xavier, Anna Lenice, Geraldo, Luiz Henrique, Carvalho da Fonseca, Anna Carolina, Correia, Ana Helena, Meirelles, Fernanda, Ventura, Grasiella, Romão, Luciana, Silva Canedo, Nathalie Henriques, Marcondes de Souza, Jorge, de Menezes, João Ricardo, Moura-Neto, Vivaldo, Tovar-Moll, Fernanda, and Lima, Flavia Regina
- Subjects
BRAIN tumor treatment ,CANCER chemotherapy ,GLIOBLASTOMA multiforme ,XENOTRANSPLANTATION ,IMMUNOSUPPRESSION ,IMMUNOCOMPETENT cells ,LABORATORY mice - Abstract
Background Glioblastoma (GBM) is the most common primary brain tumor and the most aggressive glial tumor. This tumor is highly heterogeneous, angiogenic, and insensitive to radio- and chemotherapy. Here we have investigated the progression of GBM produced by the injection of human GBM cells into the brain parenchyma of immunocompetent mice. Methods Xenotransplanted animals were submitted to magnetic resonance imaging (MRI) and histopathological analyses. Results Our data show that two weeks after injection, the produced tumor presents histopathological characteristics recommended by World Health Organization for the diagnosis of GBM in humans. The tumor was able to produce reactive gliosis in the adjacent parenchyma, angiogenesis, an intense recruitment of macrophage and microglial cells, and presence of necrosis regions. Besides, MRI showed that tumor mass had enhanced contrast, suggesting a blood--brain barrier disruption. Conclusions This study demonstrated that the xenografted tumor in mouse brain parenchyma develops in a very similar manner to those found in patients affected by GBM and can be used to better understand the biology of GBM as well as testing potential therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF